Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the combination of Abraxane and Carboplatin
together will improve the chances of controlling recurrent ovarian/fallopian tube/peritoneal
cancer.